News | May 17, 2010

Organization Promotes Quality Care in Cath Labs

May 17, 2010 – The Society for Cardiovascular Angiography and Interventions (SCAI) recently announced the creation of the Accreditation for Cardiovascular Excellence (ACE) organization. The new accrediting body, announced at SCAI’s 33rd Annual Scientific Sessions in early May, is designed to promote and uphold high-quality patient care and improve patient safety in facilities where invasive cardiac and endovascular procedures are performed.

ACE will advance excellence by providing an accrediting mechanism, based on scientific evidence in peer-reviewed medical literature and professionally determined quality metrics, to ensure processes and outcomes of cardiovascular procedures are consistent with predetermined benchmarks. ACE also makes available tools and quality improvement guidance to organizations seeking, or having achieved provisional accreditation, in order to support ongoing quality improvement and optimal patient care.

“Our primary goal for ACE is to increase the consistency of superior patient care in cardiovascular procedures throughout the U.S.,” said Bonnie Weiner, M.D., MSEC, MBA, FSCAI, president of ACE and director of interventional cardiology research at Saint Vincent Hospital at Worcester Medical Center, Worcester, Mass. “When they are treated at a cardiovascular center that is ACE-accredited, patients should feel confident the facility has taken the appropriate, evidence-based steps to help ensure the best care for each individual patient.”

Carotid Stenting
ACE will first focus on providing accreditation to hospitals that perform carotid artery stenting procedures, with subsequent expansion to other cardiovascular procedures, including percutaneous coronary interventions, other endovascular procedures and structural heart disease interventions. Currently, carotid artery stenting is reserved primarily for patients who are at high-risk for carotid endarderectomy.

“Advancing quality standards is of utmost importance in our field and in all of medicine,” said Steven R. Bailey, M.D., FSCAI, chief, division of cardiology, Janey Briscoe distinguished chair of cardiovascular research and professor of medicine and radiology at the University of Texas Health Sciences Center at San Antonio and SCAI president. “ACE will help us to work proactively to promote and maintain excellence for the patients we serve.”

ACE will begin accrediting carotid artery stenting facilities this summer. Facilities must apply for accreditation, submit data and be visited by review teams to complete the process. Part of the accreditation process will include validation of self-reported data and appropriate use of existing guidelines and knowledge of changing best practices. Accreditation will last for a two-year period, after which a review of the facility will be required for continued ACE recognition.

For more information: www.cvexcel.org

Related Content

New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium
News | Cath Lab | June 20, 2019
VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between Transcatheter...
Novel Index Accurately Predicts PCI Success Post-Procedure Compared to Established Measurement Metrics
News | Cath Lab | June 19, 2019
Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic pressure ratio (NHPR...
Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Mobility May Predict Elderly Heart Attack Survivors' Repeat Hospital Stays
News | Cath Lab | April 23, 2019
Determining which elderly heart attack patients take longer to stand from a seated position and walk across a room may...
FDA Releases New Guidance on Medical Devices Containing Nitinol
News | Cath Lab | April 18, 2019
April 18, 2019 — The U.S.
Angiography shows a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL lithoplasty.

Figure 2: Angiography demonstrates a stenotic lesion in the mid right coronary artery, undilatable by standard high-pressure balloon angioplasty (inset, arrowheads). (B) Optical coherence tomography (OCT) cross-sectional (top) and longitudinal (bottom) images acquired before IVL and coregistered to the OCT lens (arrow in A) demonstrate severe near-circumferential calcification (double-headed arrow) in the area of the stenosis. (C) Angiography demonstrates improvement in the area of stenosis after IVL (inset; note the cavitation bubbles generated by IVL [black arrows]). (D) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-IVL and coregistered to the OCT lens (white arrow in C) demonstrate multiple calcium fractures and large acute luminal gain. (E) Angiography demonstrates complete stent expansion with the semicompliant stent balloon (inset) without the need for high-pressure noncompliant balloon inflation. (F) OCT cross-sectional (top) and longitudinal (bottom) images acquired post-stenting and coregistered to the OCT lens (arrow in E) demonstrate further fracture displacement (arrow), with additional increase in the acute area gain (5.17 mm2), resulting in full stent expansion and minimal malapposition.

Feature | Cath Lab | April 15, 2019 | Dean Kereiakes, M.D., FACC, FSCAI, and Jonathan Hill, M.D., DISRUPT CAD III Co-Principal Investigators
Over the last 40 years, despite multiple advancements in percutaneous coronary interventions, calcified lesions remai
BIOTRONIK’s PK Papyrus covered coronary stent. The stent ius used in emergency coronary artery dissections to repair the vessel wall.
Technology | Cath Lab | April 15, 2019
April 15, 2019 — Biotronik began its U.S.
Overlay Init